Key points are not available for this paper at this time.
Introduction High blood pressure (HBP) is an independent, modifiable driver of cardiovascular (CV) morbidity and mortality. Nocturnal hypertension and non-dipping of blood pressure (NdBP) may be early markers of HBP. Similar to patients with NdBP, individuals with non-dipping of heart rate (NdHR) during sleep have an increased risk of CV disease, CV events, and CV-related mortality. The aim of this analysis was to evaluate if cardiopulmonary coupling (CPC) analysis-derived sleep states stable/unstable non-rapid eye movement (NREM) sleep and concomitant heart rate (HR) changes can provide information about nocturnal blood pressure (BP). Method Plethysmogram (pleth) signals from the HeartBEAT study (NCT01086800) were analyzed for CPC sleep states. Included in the analysis are sleep recordings from participants with acceptable pleth-signal quality at baseline ( n = 302) and follow-up ( n = 267), all having confirmed CV disease or CV-disease risk factors. The participants had a high prevalence of obstructive sleep apnea (OSA), 98.4% with moderate-OSA apnea–hypopnea index (AHI) ≥ 15) and 29.6% severe OSA (AHI ≥ 30). A “heart-rate module” was created to evaluate the utility of identifying patients more likely to have BP dipping during sleep. Patients who did not have a decrease of ≥10% in their BP from wake to sleep were defined as NdBP and NdHR if their heart rate during stable-NREM sleep was higher than during unstable-NREM sleep. Results The most significant difference in minimum HR (HR min ) was observed when comparing BP dippers [56 ± 4 beats per minute (BPM) and non-BP dippers (59 ± 4 BPM; p 0.0001) during diastolic blood pressure in stable-NREM sleep. Higher HR min were associated with an increased likelihood of being a non-dipper, with the strongest relationship with diastolic BP and stable-NREM sleep. Every increase of 1 BPM during stable-NREM sleep was associated with an ~4.4% increase in the probability of NdBP ( p = 0.001). Subjects with NdHR have higher mean BP during sleep and wake periods than HR dippers. When continuous positive airway pressure therapy is efficacious, and a dipping pattern is achieved—physical and mental health is improved. Conclusion HR analytics in relation to the sleep period and the CPC spectrogram-estimated sleep states can provide novel and potentially clinically useful information on autonomic health. HR dipping (or not) may be a useful screener of BP dipping or non-dipping to identify individuals who may benefit from a formal assessment of 24-h ambulatory BP. Such a stepped approach may enable a more practical and applicable approach to diagnosing HBP. Clinical Trial Registration The Heart Biomarker Evaluation in Apnea Treatment (HeartBEAT) study is registered at clinicaltrials.gov/ct2/show/NCT01086800 .
Hilmisson et al. (Thu,) studied this question.